Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum

被引：12
|
作者：
Shareef, M. S. [1 ]
Munro, L. R. [2 ]
Owen, R. G. [3 ]
Highet, A. S. [1 ]
机构：
[1] York Teaching Hosp, Dept Dermatol, York, N Yorkshire, England
[2] York Teaching Hosp, Dept Haematol, York, N Yorkshire, England
[3] St James Univ Hosp, HMDS Lab, Leeds, W Yorkshire, England
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2012年 / 37卷 / 02期
关键词：
MULTIPLE-MYELOMA; MONOCLONAL GAMMOPATHY; CRITERIA;
D O I：
10.1111/j.1365-2230.2011.04219.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Pyoderma gangrenosum (PG) may be associated with inflammatory disorders and haematological conditions such as monoclonal gammopathy of uncertain significance (MGUS). We report the case of a 53-year old man who had PG and MGUS. After treatment with infliximab for the PG, he developed myeloma. The course of events in this case suggests that infliximab facilitated the progression from MGUS to myeloma.
引用
收藏
页码：146 / 148
页数：3
相关论文
共 50 条
  • [31] IgA pemphigus associated with monoclonal gammopathy completely resolved after achievement of complete remission of multiple myeloma with bortezomib, cyclophosphamide and dexamethasone regimen
    Adam, Zdenek
    Krejci, Marta
    Pour, Ludek
    Feit, Josef
    Buechler, Tomas
    Hajek, Roman
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (9-10) : 311 - 314
  • [32] Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study
    Cowan, Annie
    Ferrari, Federico
    Freeman, Samuel S.
    Redd, Robert
    El-Khoury, Habib
    Perry, Jacqueline
    Patel, Vidhi
    Kaur, Priya
    Barr, Hadley
    Lee, David J.
    Lightbody, Elizabeth
    Downey, Katelyn
    Argyelan, David
    Theodorakakou, Foteini
    Fotiou, Despina
    Liacos, Christine Ivy
    Kanellias, Nikolaos
    Chavda, Selina J.
    Ainley, Louise
    Sandecka, Viera
    Pospisilova, Lenka
    Minarik, Jiri
    Jungova, Alexandra
    Radocha, Jakub
    Spicka, Ivan
    Nadeem, Omar
    Yong, Kwee
    Hajek, Roman
    Kastritis, Efstathios
    Marinac, Catherine R.
    Dimopoulos, Meletios A.
    Get, Gad
    Trippa, Lorenzo
    Ghobrial, Irene M.
    LANCET HAEMATOLOGY, 2023, 10 (03): : E203 - E212
  • [33] Involved/uninvolved immunoglobulin ratio identifies monoclonal gammopathy of undetermined significance patients at high risk of progression to multiple myeloma
    Espino, Mercedes
    Medina, Silvia
    Jesus Blanchard, Maria
    Villar, Luisa M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (05) : 752 - 755
  • [34] Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach
    Parisa Khalili
    Reza Maddah
    Mohsen Maleknia
    Bahareh Shateri Amiri
    Fatemeh Forouzani
    Afshin Hasanvand
    Hadi Rezaeeyan
    Molecular Biotechnology, 2023, 65 : 1275 - 1286
  • [35] Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
    Chang, Su-Hsin
    Gumbel, Jason
    Luo, Suhong
    Thomas, Theodore S.
    Sanfilippo, Kristen M.
    Luo, Jingqin
    Colditz, Graham A.
    Carson, Kenneth R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (12) : 2055 - 2061
  • [36] Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach
    Khalili, Parisa
    Maddah, Reza
    Maleknia, Mohsen
    Amiri, Bahareh Shateri
    Forouzani, Fatemeh
    Hasanvand, Afshin
    Rezaeeyan, Hadi
    MOLECULAR BIOTECHNOLOGY, 2023, 65 (08) : 1275 - 1286
  • [37] Successful Treatment of a Patient with Rheumatoid Arthritis and IgA-Kappa Multiple Myeloma with Tocilizumab
    Matsuyama, Yasushi
    Nagashima, Takao
    Honne, Kyoko
    Kamata, Yasuyuki
    Iwamoto, Masahiro
    Okazaki, Hitoaki
    Sato, Kazuya
    Ozawa, Keiya
    Minota, Seiji
    INTERNAL MEDICINE, 2011, 50 (06) : 639 - 642
  • [38] Treatment of pure red cell aplasia associated with multiple myeloma with biclonal gammopathy using cyclosporine A: a case report
    Lv, Yali
    Qian, Wenbin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (01): : 1498 - 1500
  • [39] Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
    Gran, Charlotte
    Liwing, Johan
    Wagner, Arnika Kathleen
    Verhoek, Andre
    Gezin, Ana
    Alici, Evren
    Nahi, Hareth
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (01) : 23 - 30
  • [40] Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen
    Szturz, Petr
    Adam, Zdenek
    Klincova, Maria
    Feit, Josef
    Krejci, Marta
    Pour, Ludek
    Zahradova, Lenka
    Vasku, Vladimir
    Hajek, Roman
    Mayer, Jiri
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) : 517 - 520
12345